通过性别和性别镜头定制类风湿性关节炎治疗
Loreto Carmona1, Elena Aurrecoechea2, María Jesús García de Yébenes1
1Instituto de Salud Musculoesquelética, 28045 Madrid, Spain.
Journal of clinical medicine
|January 11, 2024
概括
本研究探讨了类风湿性关节炎 (RA) 临床表现和预后的性别和性别差异. 了解这些差异对于开发针对 RA 患者的个性化医疗方法至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 医学中的性别和性别.
背景情况:
- 风湿性关节炎 (RA) 不成比例地影响女性.
- 现有的关于RA的性别和性别差异的研究是有限的,并产生了相互矛盾的结果.
- 方法上的挑战阻碍了对这些差异的清晰理解.
研究的目的:
- 调查RA临床表现和预后的性别和性别相关差异.
- 评估性别和性别对精神社会因素,应对机制和RA患者获得医疗保健的影响.
- 为 RA 个人化治疗策略的开发提供信息.
主要方法:
- 该研究评估了RA的性别和性别相关差异.
- 它评估了临床表现,预后,心理社会变量,应对行为和医疗保健利用率.
- 这项研究的目的是确定量身定制的治疗方法的差异.
主要成果:
- 在临床表达和预后方面,RA表现出显著的性别和性别差异.
- 这些差异影响心理社会变量,应对策略和医疗保健准入.
- 性别和年龄是个性化RA医学的关键决定因素.
结论:
- 识别RA中的性别和性别差异对于个性化医学至关重要.
- 需要量身定制的治疗策略来解决RA患者的特定需求和差异.
- 将性别和性别考虑纳入RA管理可以改善患者的治疗结果.
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127


